Correction: Use of the 'Accountability for Reasonableness' approach to improve fairness in accessing dialysis in a middle-income country (PLoS ONE (2016) 11: 10 (e0164201) DOI: 10.1371/journal.pone.0164201);Use of the 'accountability for reasonableness' approach to improve fairness in accessing dialysis in a middle-income country

PLoS ONE

Volumn 11, Issue 10, 2016, Pages

  Moosa, Mohammed Rafique ^a,b   Maree, Jonathan David ^b   Chirehwa, Maxwell T ^a   Benatar, Solomon R ^c  

^a UNIVERSITY OF STELLENBOSCH   (South Africa)

^b STELLENBOSCH UNIVERSITY   (South Africa)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DECISION MAKING; DESCRIPTIVE RESEARCH; DIALYSIS; EDUCATIONAL STATUS; EMPLOYMENT STATUS; FEMALE; GRAFT SURVIVAL; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH ECONOMICS; HEALTH INSURANCE; HEPATITIS B; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LIFE EXPECTANCY; LIVING DONOR; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MIDDLE INCOME COUNTRY; OBESITY; PATIENT SELECTION; RENAL REPLACEMENT THERAPY; RURAL AREA; SEX DIFFERENCE; SOCIOECONOMICS; SOUTH AFRICA; DEVELOPING COUNTRY; ECONOMICS; HEALTH CARE DELIVERY; HEALTH CARE ORGANIZATION; HEMODIALYSIS; MIDDLE AGED; ORGANIZATION; PROCEDURES; SOCIAL BEHAVIOR;

ADULT; DECISION MAKING, ORGANIZATIONAL; DEVELOPING COUNTRIES; FEMALE; HEALTH CARE RATIONING; HEALTH SERVICES ACCESSIBILITY; HUMANS; MALE; MIDDLE AGED; PATIENT SELECTION; RENAL DIALYSIS; SOCIAL RESPONSIBILITY;

EID: 84991461478     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0168017     Document Type: Erratum

References (73)

1. White SL, Chadban SJ, Jan S, Chapman JR, Cass A. How can we achieve global equity in provision of renal replacement therapy? Bull World Health Organ. 2008;86:229-237. S0042-96862008000300017 [pii]. doi: 10.2471/BLT.07.041715 PMID: 18368211
2. Lysaght MJ. Maintenance dialysis population dynamics: current trends and long-term implications. J Am Soc Nephrol. 2002;13 Suppl 1:S37-S40. PMID: 11792760
3. United States Renal Data System 2015 USRDS annual data report: Epidemiology of kidney disease in the United Sates. 2015 National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2015.
4. The World Bank Total Health Expenditure. 2015. Available: (http://data.worldbank.org/indicator/SH. XPD. TOTL. ZS). Accessed 16 June 2016.
5. Nugent RA, Fathima SF, Feigl AB, Chyung D. The burden of chronic kidney disease on developing nations: a 21st century challenge in global health. Nephron Clin Pract. 2011;118:c269-c277. 000321382 [pii]; doi: 10.1159/000321382 PMID: 21212690
6. Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, et al. Chronic kidney disease: global dimension and perspectives. Lancet 2013;382:260-272. S0140-6736 (13) 60687-X [pii]; doi: 10.1016/S0140-6736 (13) 60687-X PMID: 23727169
7. Grassmann A, Gioberge S, Moeller S, Brown G. ESRD patients in 2004: global overview of patient numbers, treatment modalities and associated trends. Nephrol Dial Transplant. 2005;20:2587-2593. doi: 10.1093/ndt/gfi159 PMID: 16204281
8. Eggers PW. Has the incidence of end-stage renal disease in the USA and other countries stabilized? Curr Opin Nephrol Hypertens. 2011;20:241-245. doi: 10.1097/MNH.0b013e3283454319 PMID: 21422925
9. Kher V. End-stage renal disease in developing countries. Kidney Int. 2002;62:350-362. kid426 [pii]; doi: 10.1046/j.1523-1755.2002.00426.x PMID: 12081600
10. Bamgboye EL. Barriers to a functional renal transplant program in developing countries. Ethn Dis 2009;19:S1-S9. PMID: 19484877
11. Moosa MR, Meyers AM, Gottlich E, Naicker S. An effective approach to chronic kidney disease in South Africa. S Afr Med J. 2016;106:156-159. doi: 10.7196/SAMJ.2016.v106i2.9928 PMID: 26821893
12. Moosa MR, Kidd M. The dangers of rationing dialysis treatment: the dilemma facing a developing country. Kidney Int. 2006;70:1107-1114. 5001750 [pii]; doi: 10.1038/sj.ki.5001750 PMID: 16883316
13. Moosa MR. Impact of age, gender and race on patient and graft survival following renal transplantation Ddeveloping country experience. S Afr Med J. 2003;93:689-695. PMID: 14635558
14. Martin D, Singer P. A strategy to improve priority setting in health care institutions. Health Care Anal. 2003;11:59-68. doi: 10.1023/A:1025338013629 PMID: 14510309
15. Daniels N, Sabin J. The ethics of accountability in managed care reform. Health Aff. (Millwood) 1998;17:50-64. doi: 10.1377/hlthaff.17.5.50 PMID: 9769571
16. Moosa MR. Guideline: Priority setting approach in the selection of patients in the public sector with end-stage kidney failure for renal replacement treatment in the Western Cape Province; 2013. Available: http://s3.documentcloud.org/documents/19489/moosa-priority-setting-policy-final-feb-24-2010-final.pdf. Accessed 10 June 2016
17. Barsoum RS. End-stage renal disease in North Africa. Kidney Int Suppl. 2003; S111-S114. kid8322 [pii]; doi: 10.1046/j.1523-1755.63.s83.23.x PMID: 12864887
18. Shaheen FA, Al-Khader AA. Preventive strategies of renal failure in the Arab world. Kidney Int Suppl. 2005; S37-S40. KID9807 [pii]; doi: 10.1111/j.1523-1755.2005.09807.x PMID: 16108969
19. Murphy D, McCulloch CE, Lin F, Banerjee T, Bragg-Gresham JL, Eberhardt MS, et al. Trends in prevalence of chronic kidney disease in the United States. Trends in prevalence of chronic kidney disease in the United States. Ann Internl Med. 2016; doi: 10.7326/M16-0273 PMID: 27479614
20. Benatar SR, Gill S, Bakker I. Global health and the global economic crisis. Am J Public Health. 2011;101:646-653. AJPH.2009.188458 [pii]; doi: 10.2105/AJPH.2009.188458 PMID: 21330597
21. Sakhuja V, Sud K. End-stage renal disease in India and Pakistan: burden of disease and management issues. Kidney Int Suppl. 2003; S115-S118. kid8323 [pii]; doi: 10.1046/j.1523-1755.63.s83.24.x PMID: 12864888
22. Garcia-Garcia G, Monteon-Ramos JF, Garcia-Bejarano H, Gomez-Navarro B, Reyes IH, Lomeli AM, et al. Renal replacement therapy among disadvantaged populations in Mexico: A report from the Jalisco Dialysis and Transplant Registry (REDTJAL). Kidney Int. 2005;68:S58-S61. doi: 10.1111/j. 1523-1755.2005.09710.x PMID: 16014102
23. Sakhuja V, Kohli HS. End-stage renal disease in India and Pakistan: incidence, causes, and management. Ethn Dis. 2006;16:S2-S3. PMID: 16774005
24. Naicker S, Bello AK, El Nahas M. Chronic kidney diseases: Focus on Africa. In: El Nahas M, editor. Kidney diseases in the developing world and ethnic minorities. London: Taylor and Francis. 2005; pp. 137-160. doi: 10.1201/b14128-8
25. Etheredge HR, Turner RE, Kahn D. Public attitudes to organ donation among a sample of urban-dwelling South African adults: a 2012 study. Clin Transplant. 2013;27:684-692. doi: 10.1111/ctr.12200 PMID: 23968357
26. Bass D. Kidneys for cash and egg safarisDcan we allow 'transplant tourism' to flourish in South Africa? S Afr Med J. 2005;95:42-44. PMID: 15762247
27. Scheper-Hughes N. Keeping an eye on the global traffic in human organs. Lancet. 2003;361:1-45-1648. doi: 10.1016/S0140-6736 (03) 13305-3 PMID: 12747896
28. Kevany S, Benatar SR, Fleischer T. Improving resource allocation decisions for health and HIV programmes in South Africa: Bioethical, cost-effectiveness and health diplomacy considerations. Glob Public Health 2013;8:570-587. doi: 10.1080/17441692.2013.790461 PMID: 23651436
29. Mayosi BM, Benatar SR. Health and health care in South AfricaD20 years after Mandela. N Engl J Med. 2014;371:1344-1353. doi: 10.1056/NEJMsr1405012 PMID: 25265493
30. Benatar S. Facing ethical challenges in rolling out antiretroviral treatment in resource-poor countries: comment on "They call it 'patient selection' in Khayelitsha. Camb Q Health Ethics 2006;15:322-330. doi: 10.1017/S0963180106060427 PMID: 16862936
31. [Anonymous] (1998) Soobramoney v. Minister of Health, Kwa-Zulu Natal. (1998). (1) SA 765 (South African Constitutional Court).
32. Benatar SR. Health Care Reform and the Crisis of HIV and AIDS in South Africa. N Engl J Med. 2004;351:81-92. doi: 10.1056/NEJMhpr033471 PMID: 15229313
33. Daniels N. and Sabin J. Setting Limits Fairly: Can We Learn to Share Medical Resources? Oxford: 2002; Oxford University Press. doi: 10.1093/acprof:oso/9780195149364.001.0001
34. Gibson J, Mitton C, Martin D, Donaldson C, Singer P. Ethics and economics: does programme budgeting and marginal analysis contribute to fair priority setting? J Health Serv Res Policy. 2006;11:32-37. doi: 10.1258/135581906775094280 PMID: 16378530
35. Marckmann G, Schmidt H, Sofaer N, Strech D. Putting public health ethics into practice: A systematic framework. Frontiers in Public Health. 2015;3:23, e1-e8. doi: 10.3389/fpubh.2015.00023 PMID: 25705615
36. Benatar SR, Ashcroft R. International perspectives on resource allocation. Reference Module in Biomedical Sciences. Elsevier. 2015; http://dx.doi.org/10.1016/B978-0-12-801238-3.92830-7
37. Faravardeh A, Eickhoff M, Jackson S, Spong R, Kukla A, Issa N, et al. Predictors of graft failure and death in elderly kidney transplant recipients. Transplantation. 2013;96:1089-1096. doi: 10.1097/TP. 0b013e3182a688e5 PMID: 24056622
38. Fabrizii V, Winkelmayer WC, Klauser R, Kletzmayr J, Säemann MD, Steininger et al. Patient and graft survival in older kidney transplant recipients: Does age matter? J Am Soc Nephrol. 2004;15:1-52-1060. doi: 10.1097/01. ASN.0000120370.35927.40 PMID: 15034109
39. Saudan P, Berney T, Leski M, Morel P, Bolle JF, Martin PY. Renal transplantation in the elderly: a long-term, single-centre experience. Nephrol Dial Transplant. 2001;16:824-828. doi: 10.1093/ndt/16.4.824 PMID: 11274281
40. Alexander S. They Decide Who Lives, Who Dies: Medical miracle and a moral burden of a small committee. Life: 1962;53 September 9:102-125.
41. Persad G, Wertheimer A, Emanuel EJ. Principles for allocation of scarce medical interventions. Lancet. 2009;373:423-431. doi: 10.1016/S0140-6736 (09) 60137-9 PMID: 19186274
42. Callahan D. D. Setting limits: medical goals in an aging society. Washington, DC: Georgetown University Press; 1995.
43. Daniels Norman. Am I my parents' keeper? An essay on justice between the young and the old. Oxford University Press; 1988.
44. Williams A, Evans JG. The rationing debate: Rationing health care by age. BMJ. 1997;314:8-0. doi: 10.1136/bmj.314.7083.820 PMID: 9081009
45. Rutecki GW. Would treatment allocation according to age-contingent depreciation be ethical? A dialysis and transplantation paradigm. Ethic Med. 2016;27:99-107.
46. Ng M, Fleming T, Robinson M, Thomson B, Graetz N, Margono C, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014;384:766-781. S0140-6736 (14) 60460-8 [pii]; doi: 10.1016/S0140-6736 (14) 60460-8 PMID: 24880830
47. Curran SP, Famure Y, Li Z, Kim SJ. Increased recipient body mass index is associated with acute rejection and other adverse outcomes after kidney transplantation. Transplantation 2014;97:64-70. doi: 10.1097/TP.0b013e3182a688a4 PMID: 24056619
48. Aalten J, Christiaans MH, de Fijter H, Hene R, van der Heijde JH, Roodnat J, el at. The influence of obesity on short- and long-term graft and patient survival after renal transplantation. Transpl Int. 2006;19:901-907. TRI367 [pii]; doi: 10.1111/j.1432-2277.2006.00367.x PMID: 17018125
49. Gore JL, Pham PT, Danovitch GM, Wilkinson AH, Rosenthal JT, Lipshutz GS, el at. Obesity and outcome following renal transplantation. Am J Transplant. 2006;6:357-363. AJT1198 [pii]; doi: 10.1111/j.1600-6143.2005.01198.x PMID: 16426321
50. Cosio FG, Hickson LJ, Griffin MD, Stegall MD, Kudva Y. Patient survival and cardiovascular risk after kidney transplantation: the challenge of diabetes. Am J Transplant. 2008;8:593-599. AJT2101 [pii]; doi: 10.1111/j.1600-6143.2007.02101.x PMID: 18294155
51. Revanur VK, Jardine AG, Kingsmore DB, Jaques BC, Hamilton DH, Jindal RM. Influence of diabetes mellitus on patient and graft survival in recipients of kidney transplantation. Clin Transplant. 2001;15:89-94. ctr150202 [pii]. doi: 10.1034/j.1399-0012.2001.150202.x PMID: 11264633
52. Cosio FG, Pesavento TE, Kim S, Osei K, Henry M, Ferguson RM. Patient survival after renal transplantation: IV. Impact of post-transplant diabetes. Kidney Int 2002;62:1440-1446. kid582 [pii]; doi: 10.1111/j.1523-1755.2002.kid582.x PMID: 12234317
53. Muller E, Kahn D, Mendelson M. Renal Transplantation between HIV-Positive Donors and Recipients. N Engl J Med. 2010;362:2336-2337. doi: 10.1056/NEJMc0900837 PMID: 20554994
54. Roland ME, Barin B, Carlson L, Frassetto LA, Terrault NA, Hirose R, et al. HIV-Infected Liver and Kidney Transplant Recipients: 1- and 3-Year Outcomes. Am J Transplant. 2008;8:355-365. doi: 10. 1111/j.1600-6143.2007.02061.x PMID: 18093266
55. Stock PG, Barin B, Murphy B, Hanto D, Diego JM, Light J, et al. Outcomes of kidney transplantation in HIV-infected recipients. N Engl J Med. 2010;363:2004-2014. doi: 10.1056/NEJMoa1001197 PMID: 21083386
56. Harnett JD, Zeldis JB, Parfrey PS, Kennedy M, Sircar R, Steinmann TI, et al. Hepatitis B disease in dialysis and transplant patients. Further epidemiologic and serologic studies. Transplantation. 1987;44:369-376. doi: 10.1097/00007890-198709000-00009 PMID: 2820093
57. Gane E, Pilmore H. Management of chronic viral hepatitis before and after renal transplantation. Transplantation. 2002;74:427-437. doi: 10.1097/00007890-200208270-00001 PMID: 12352899
58. Yap DY, Chan TM. Evolution of hepatitis B management in kidney transplantation. World J Gastroenterol. 2014;20:468-474. doi: 10.3748/wjg.v20.i2.468 PMID: 24574715
59. Yap DY, Tang CS, Yung S, Choy BY, Yuen MF, Chan TM. Long-term outcome of renal transplant recipients with chronic hepatitis B infection-impact of antiviral treatments. Transplantation. 2010;90:325-330. doi: 10.1097/TP.0b013e3181e5b811 PMID: 20562676
60. Denhaerynck K, Steiger J, Bock A, Schäfer-Keller P, Kö fer S, Thannberger N, el at. Prevalence and Risk Factors of Non-Adherence with Immunosuppressive Medication in Kidney Transplant Patients. Am J Transplant. 2007;7:108-116. doi: 10.1111/j.1600-6143.2006.01611.x PMID: 17109727
61. Cosio FG, Falkenhain ME, Pesavento TE, Yim S, Alamir A, Henry ML, el at. Patient survival after renal transplantation: II. The impact of smoking. Clin Transplant. 1999;13:336-341. doi: 10.1034/j.1399-0012.1999.130410.x PMID: 10485376
62. Hurst FP, Altieri M, Patel PP, Jindal TR, Guy SR, Sidawy AN, el at. Effect of Smoking on Kidney Transplant Outcomes: Analysis of the United States Renal Data System. Transplantation 2011;92:1-01-1107. doi: 10.1097/TP.0b013e3182336095 PMID: 21956202
63. Moosa MR. Impact of age, gender and race on patient and graft survival following renal transplantation Ddeveloping country experience. S Afr Med J. 2003;93:689-695. PMID: 14635558
64. Dogan E, Erkoc R, Sayarlioglu H, Durmus A, Topal C (2005) Effects of late referral to a nephrologist in patients with chronic renal failure. Nephrology. 2003;10:516-519. doi: 10.1111/j.1440-1797.2005. 00433.x PMID: 16221105
65. Smart NA, Titus TT. Outcomes of Early versus Late Nephrology Referral in Chronic Kidney Disease: A Systematic Review. Am J Med. 2011;124:1073-1080. doi: 10.1016/j.amjmed.2011.04.026 PMID: 22017785
66. Maluka S, Kamuzora P, San SM, Byskov J, Olsen OE, Shayo E, el at. Decentralized health care prioritysetting in Tanzania: evaluating against the accountability for reasonableness framework. Soc Sci Med. 2010;71:751-759. S0277-9536 (10) 00384-9 [pii]; doi: 10.1016/j.socscimed.2010.04.035 PMID: 20554365
67. Byskov J, Bloch P, Blystad A, Hurtig AK, Fylkesnes K, Kamuzora P, el at. Accountable priority setting for trust in health systems the need for research into a new approach for strengthening sustainable health action in developing countries. Health Res Policy Syst. 2009;7:23. 1478-4505-7-23 [pii]; doi: 10.1186/1478-4505-7-23 PMID: 19852834
68. Norheim OF. Ethical priority setting for universal health coverage: challenges in deciding upon fair distribution of health services. BMC Med. 2016;14:75. doi: 10.1186/s12916-016-0624-4 [pii]. PMID: 27170046
69. Norheim OF, Baltussen R, Johri M, Chisholm D, Nord E, Brock D, el at. Guidance on priority setting in health care (GPS-Health): the inclusion of equity criteria not captured by cost-effectiveness analysis. Cost Eff Resour Alloc. 2014;12:18. doi: 10.1186/1478-7547-12-18 PMID: 25246855
70. Moosa MR. Kidney transplantation in developing countries. In: Morris PJ, Knechtle SJ, editors. Kidney transplantation: Principles and practice. London: Elsevier Saunders. 2014; pp. 643-675.
71. Vachharajani TJ, Moist LM, Glickman MH, Vazquez MA, Polkinghorne KR, Lok CE, el at. Elderly patients with CKD-dilemmas in dialysis therapy and vascular access. Nat Rev Nephrol. 2014;10:116-122. doi: 10.1038/nrneph.2013.256 PMID: 24296629
72. Carson RC, Juszczak M, Davenport A, Burns A. Is maximum conservative management an equivalent treatment option to dialysis for elderly patients with significant comorbid disease? Clin J Am Soc Nephrol. 2009;4:1611-1619. doi: 10.2215/CJN.00510109 PMID: 19808244
73. Daniels N. Accountability for reasonableness. BMJ. 2000;321:1300-1301. doi: 10.1136/bmj.321. 7272.1300 PMID: 11090498